Puja P Hazari Selected Research

Puja P Hazari Research Topics

Disease

9	Neoplasms (Cancer) 09/2020 - 03/2011
3	Glioma (Gliomas) 09/2021 - 10/2015
2	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2011
2	Pneumonia (Pneumonitis) 06/2022 - 01/2018
2	Inflammation (Inflammations) 06/2022 - 01/2018
2	Fibrosis (Cirrhosis) 06/2022 - 01/2018
2	Infections 01/2015 - 04/2013
1	Thoracic Neoplasms 06/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Herpes Zoster 01/2021
1	Lung Injury 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Pain (Aches) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 05/2015
1	Bacterial Infections (Bacterial Infection) 04/2013
1	Carcinoma (Carcinomatosis) 10/2012
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2012

Drug/Important Bio-Agent (IBA)

4	Choline (Choline Chloride)IBA 04/2024 - 03/2011
3	Methionine (L-Methionine)FDA Link 09/2021 - 10/2015
3	Pentetic Acid (DTPA)FDA LinkGeneric 09/2021 - 10/2012
2	Amifostine (Ethyol)FDA LinkGeneric 06/2022 - 01/2018
2	CreatineIBA 09/2020 - 03/2017
2	RadiopharmaceuticalsIBA 01/2015 - 10/2012
2	Chelating AgentsIBA 01/2013 - 03/2011
2	Peptides (Polypeptides)IBA 01/2013 - 04/2012
1	Technetium Tc 99m PentetateIBA 04/2024
1	CollagenIBA 06/2022
1	Hydroxyproline (4 Hydroxyproline)IBA 06/2022
1	Indicators and Reagents (Reagents)IBA 09/2021
1	CarbonIBA 01/2021
1	CatalaseIBA 01/2021
1	QuercetinIBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	OccludinIBA 01/2021
1	Laminin (Merosin)IBA 01/2021
1	N-acetylaspartate (N-acetyl aspartate)IBA 09/2020
1	AntioxidantsIBA 01/2018
1	CytokinesIBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	(18F)fluoroethyltyrosineIBA 03/2017
1	phosphonic acidIBA 01/2017
1	AcidsIBA 01/2017
1	alovudineIBA 10/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2015
1	Citric Acid (Citrate)FDA LinkGeneric 01/2015
1	Antimicrobial PeptidesIBA 01/2015
1	LipopolysaccharidesIBA 01/2015
1	DepsipeptidesIBA 01/2015
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2013
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2013
1	Third Generation CephalosporinsIBA 04/2013
1	GalliumIBA 01/2013
1	bombesin receptor subtype 3IBA 01/2013
1	IonsIBA 01/2013
1	MetalsIBA 01/2013
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2013
1	Gastrin-Releasing PeptideIBA 01/2013
1	Amino Acids FDA Link 10/2012
1	Octreotide (Sandostatin)FDA LinkGeneric 04/2012
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2012
1	LigandsIBA 04/2012

Therapy/Procedure

2	Radiotherapy 06/2022 - 10/2015
2	Chemoradiotherapy 09/2021 - 03/2017
1	Precision Medicine 01/2017
1	Drug Therapy (Chemotherapy) 05/2015
1	Therapeutics 04/2012